Dash Pharma

Dash Pharma

达石药业

Dash Pharma

Biotech/Healthcare

Dashi Pharma is an innovative antibody drug developer focused on novel biotech therapies, primarily antibody drugs for oncology. Two drug molecules have entered preclinical development.

Latest round: Series B (2023)

Source: ChinaBulls — chinabulls.com

Last updated 2023-01-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.